These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

490 related articles for article (PubMed ID: 26819354)

  • 1. Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry.
    Sweeney J; Patterson CC; Menzies-Gow A; Niven RM; Mansur AH; Bucknall C; Chaudhuri R; Price D; Brightling CE; Heaney LG;
    Thorax; 2016 Apr; 71(4):339-46. PubMed ID: 26819354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of long-term systemic glucocorticoid use in severe asthma: A UK retrospective cohort analysis.
    Daugherty J; Lin X; Baxter R; Suruki R; Bradford E
    J Asthma; 2018 Jun; 55(6):651-658. PubMed ID: 28925768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age and Sex Associations with Systemic Corticosteroid-Induced Morbidity in Asthma.
    Barry LE; O'Neill C; Patterson C; Sweeney J; Price D; Heaney LG
    J Allergy Clin Immunol Pract; 2018; 6(6):2014-2023.e2. PubMed ID: 29684579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost of systemic corticosteroid-induced morbidity in severe asthma: a health economic analysis.
    Barry LE; Sweeney J; O'Neill C; Price D; Heaney LG
    Respir Res; 2017 Jun; 18(1):129. PubMed ID: 28651591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma.
    Julien JY; Martin JG; Ernst P; Olivenstein R; Hamid Q; Lemière C; Pepe C; Naor N; Olha A; Kimoff RJ
    J Allergy Clin Immunol; 2009 Aug; 124(2):371-6. PubMed ID: 19560194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral corticosteroid exposure and adverse effects in asthmatic patients.
    Sullivan PW; Ghushchyan VH; Globe G; Schatz M
    J Allergy Clin Immunol; 2018 Jan; 141(1):110-116.e7. PubMed ID: 28456623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry.
    O'Neill S; Sweeney J; Patterson CC; Menzies-Gow A; Niven R; Mansur AH; Bucknall C; Chaudhuri R; Thomson NC; Brightling CE; O'Neill C; Heaney LG;
    Thorax; 2015 Apr; 70(4):376-8. PubMed ID: 24917087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled corticosteroids in children with persistent asthma: effects on growth.
    Zhang L; Prietsch SO; Ducharme FM
    Evid Based Child Health; 2014 Dec; 9(4):829-930. PubMed ID: 25504972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of inhaled and oral corticosteroids and the long-term risk of cataract.
    Wang JJ; Rochtchina E; Tan AG; Cumming RG; Leeder SR; Mitchell P
    Ophthalmology; 2009 Apr; 116(4):652-7. PubMed ID: 19243828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity-associated severe asthma represents a distinct clinical phenotype: analysis of the British Thoracic Society Difficult Asthma Registry Patient cohort according to BMI.
    Gibeon D; Batuwita K; Osmond M; Heaney LG; Brightling CE; Niven R; Mansur A; Chaudhuri R; Bucknall CE; Rowe A; Guo Y; Bhavsar PK; Chung KF; Menzies-Gow A
    Chest; 2013 Feb; 143(2):406-414. PubMed ID: 23064546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies.
    Chalitsios CV; Shaw DE; McKeever TM
    Thorax; 2021 Jan; 76(1):21-28. PubMed ID: 33087546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial.
    Patel M; Pilcher J; Pritchard A; Perrin K; Travers J; Shaw D; Holt S; Harwood M; Black P; Weatherall M; Beasley R;
    Lancet Respir Med; 2013 Mar; 1(1):32-42. PubMed ID: 24321802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morbidity associated with oral corticosteroids in patients with severe asthma.
    Choo XN; Pavord ID
    Thorax; 2016 Apr; 71(4):302-4. PubMed ID: 26903592
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of severe asthma and low asthma control among Danish adults.
    von Bülow A; Kriegbaum M; Backer V; Porsbjerg C
    J Allergy Clin Immunol Pract; 2014; 2(6):759-67. PubMed ID: 25439368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M; Beasley R; Ayres J; Slavin R; Hébert J; Bousquet J; Beeh KM; Ramos S; Canonica GW; Hedgecock S; Fox H; Blogg M; Surrey K
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Severe Asthma Worldwide: Data From the International Severe Asthma Registry.
    Wang E; Wechsler ME; Tran TN; Heaney LG; Jones RC; Menzies-Gow AN; Busby J; Jackson DJ; Pfeffer PE; Rhee CK; Cho YS; Canonica GW; Heffler E; Gibson PG; Hew M; Peters M; Harvey ES; Alacqua M; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Murray RB; Price DB
    Chest; 2020 Apr; 157(4):790-804. PubMed ID: 31785254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
    Stanford RH; Blanchette CM; Roberts MH; Petersen H; Fuhlbrigge AL
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of older age and age of asthma onset on clinical and inflammatory variables in severe refractory asthma.
    Chaudhuri R; McSharry C; Heaney LG; Niven R; Brightling CE; Menzies-Gow AN; Bucknall C; Mansur AH; Lee W; Shepherd M; Spears M; Cowan DC; Husi H; Thomson NC;
    Respir Med; 2016 Sep; 118():46-52. PubMed ID: 27578470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.